BioCentury
ARTICLE | Clinical News

Collgard Biopharmaceuticals Inc. preclinical data

April 2, 2001 7:00 AM UTC

In a mouse xenograft model of prostate cancer, oral or injected Halofuginone given before or after tumor cell injection, decreased tumor weight and size by 4-5 times over a 21-day period. The compound...